AG˹ٷ

STOCK TITAN

Petco Reports Second Quarter 2025 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Petco (NASDAQ: WOOF) reported Q2 2025 financial results with mixed performance. The company generated net sales of $1.5 billion, representing a 2.3% year-over-year decrease, while comparable sales declined 1.4%. Despite lower sales, Petco showed improved profitability with gross profit margin expanding 120 basis points to 39.3%.

Operating income improved significantly by $40.6 million to $43.0 million, and GAAP net income increased by $38.8 million to $14.0 million. Adjusted EBITDA rose by $30.3 million to $113.9 million. Based on these results, Petco maintained its full-year net sales outlook while raising its earnings guidance, projecting Adjusted EBITDA between $385-395 million for fiscal 2025.

Petco (NASDAQ: WOOF) ha pubblicato i risultati del secondo trimestre 2025 con esiti contrastanti. L'azienda ha registrato ricavi netti per 1,5 miliardi di dollari, in calo del 2,3% rispetto all'anno precedente, mentre le vendite comparabili sono diminuite dell'1,4%. Nonostante la flessione dei ricavi, la redditività è migliorata con il margine lordo salito di 120 punti base al 39,3%.

L'utile operativo è aumentato in modo significativo, salendo di 40,6 milioni a 43,0 milioni di dollari, e l'utile netto GAAP è cresciuto di 38,8 milioni portandosi a 14,0 milioni. L'EBITDA rettificato è salito di 30,3 milioni raggiungendo 113,9 milioni. Sulla base di questi risultati, Petco ha confermato la previsione dei ricavi per l'intero esercizio e ha rialzato le stime sugli utili, prevedendo un Adjusted EBITDA tra 385 e 395 milioni di dollari per il 2025 fiscale.

Petco (NASDAQ: WOOF) presentó resultados del segundo trimestre de 2025 con un desempeño mixto. La compañía registró ventas netas de 1.500 millones de dólares, una disminución interanual del 2,3%, mientras que las ventas comparables bajaron un 1,4%. A pesar de la caída en ventas, la rentabilidad mejoró con el margen bruto expandiéndose 120 puntos básicos hasta el 39,3%.

El ingreso operativo mejoró de forma notable, aumentando 40,6 millones hasta 43,0 millones de dólares, y el beneficio neto GAAP creció 38,8 millones hasta 14,0 millones. El EBITDA ajustado subió 30,3 millones hasta 113,9 millones. Con estos resultados, Petco mantuvo su previsión de ventas para el año y elevó su guía de ganancias, proyectando un Adjusted EBITDA entre 385 y 395 millones de dólares para el ejercicio fiscal 2025.

Petco (NASDAQ: WOOF)� 2025 회계연도 2분기 실적� 혼재� 성적으로 발표했습니다. 회사� 15� 달러� 순매�� 기록� 전년 대� 2.3% 감소했으�, 비교 매출은 1.4% 하락했습니다. 매출은 줄었지� 총이익률� 120베이시스포인� 확대되어 39.3%� 개선되는 � 수익성은 향상되었습니�.

영업이익은 크게 개선되어 4,060� 달러 증가� 4,300� 달러� 기록했고, GAAP 기준 순이익은 3,880� 달러 증가� 1,400� 달러� 기록했습니다. 조정 EBITDA� 3,030� 달러 증가� 1�1,390� 달러가 되었습니�. 이를 바탕으로 Petco� 연간 순매� 전망� 유지하면� 이익 가이던스를 상향 조정� 2025 회계연도� 조정 EBITDA� 3�8,500만~3�9,500� 달러� 제시했습니다.

Petco (NASDAQ: WOOF) a publié des résultats pour le deuxième trimestre 2025 au bilan mitigé. La société a réalisé des ventes nettes de 1,5 milliard de dollars, soit une baisse de 2,3% sur un an, tandis que les ventes comparables ont reculé de 1,4%. Malgré la baisse des ventes, la rentabilité s'est améliorée avec une marge brute en hausse de 120 points de base, à 39,3%.

Le résultat d'exploitation s'est nettement amélioré, augmentant de 40,6 millions pour atteindre 43,0 millions de dollars, et le résultat net GAAP a progressé de 38,8 millions pour s'établir à 14,0 millions. L'EBITDA ajusté a augmenté de 30,3 millions pour atteindre 113,9 millions. Sur la base de ces chiffres, Petco a maintenu ses prévisions de ventes annuelles tout en relevait ses objectifs de bénéfices, prévoyant un Adjusted EBITDA compris entre 385 et 395 millions de dollars pour l'exercice 2025.

Petco (NASDAQ: WOOF) veröffentlichte die Ergebnisse für das zweite Quartal 2025 mit gemischter Performance. Das Unternehmen erzielte Nettoerlöse von 1,5 Milliarden US-Dollar, ein Rückgang von 2,3% gegenüber dem Vorjahr, während die vergleichbaren Umsätze um 1,4% sanken. Trotz geringerer Umsätze verbesserte sich die Profitabilität und die Bruttomarge dehnte sich um 120 Basispunkte auf 39,3% aus.

Das Betriebsergebnis verbesserte sich deutlich um 40,6 Millionen auf 43,0 Millionen US-Dollar, und der GAAP-Nettogewinn stieg um 38,8 Millionen auf 14,0 Millionen. Das bereinigte EBITDA kletterte um 30,3 Millionen auf 113,9 Millionen. Vor dem Hintergrund dieser Ergebnisse hielt Petco seine Jahresumsatzprognose aufrecht und hob die Gewinnprognose an, mit einer erwarteten Adjusted EBITDA zwischen 385 und 395 Millionen US-Dollar für das Geschäftsjahr 2025.

Positive
  • Gross profit margin expanded 120 basis points to 39.3%
  • Operating income improved significantly by $40.6 million to $43.0 million
  • GAAP net income improved $38.8 million to $14.0 million
  • Adjusted EBITDA increased $30.3 million to $113.9 million
  • Company raised full-year 2025 earnings outlook
Negative
  • Net sales decreased 2.3% year over year to $1.5 billion
  • Comparable sales declined 1.4% year over year
  • Planning approximately 25 net store closures for FY 2025
  • Projecting continued sales decline in Q3 2025

Insights

Petco delivered earnings improvement despite sales decline, raised guidance signals operational efficiency despite retail challenges.

Petco's Q2 results present a mixed picture with some encouraging signs of financial discipline. While net sales declined 2.3% to $1.5 billion and comparable sales fell 1.4%, the company demonstrated significant improvement in profitability metrics. Gross margin expanded by 120 basis points to 39.3%, operating income improved by $40.6 million to $43.0 million, and net income turned positive at $14.0 million, a $38.8 million improvement year-over-year.

The adjusted EBITDA increase of $30.3 million to $113.9 million indicates stronger underlying operational performance, allowing management to raise full-year earnings guidance while maintaining revenue projections. This suggests cost optimization measures are taking effect despite persistent top-line pressure in the pet retail sector.

The revised full-year outlook projects continued revenue challenges with low single-digit declines, but adjusted EBITDA is now expected between $385-$395 million. The planned closure of approximately 25 net stores points to strategic consolidation of the retail footprint. With capital expenditures projected at $125-$130 million and elevated interest expenses of around $130 million, management appears focused on improving store-level economics while managing debt obligations.

CEO Joel Anderson's remarks about "strengthening our economic model" and "improving retail operating fundamentals" align with the financial results, suggesting the transformation strategy prioritizes margin enhancement over immediate sales growth. The mention of "targeted investments" indicates a selective approach to growth initiatives while maintaining financial discipline. This balanced approach may position Petco for more sustainable performance once the current retail headwinds subside.

Raises Fiscal 2025 Earnings Outlook*

SAN DIEGO, Aug. 28, 2025 /PRNewswire/ -- Petco (Nasdaq: WOOF) today announced its second quarter 2025 financial results.

Q2 2025 Overview

  • Net sales of $1.5 billion decreased 2.3% year over year in line with the company's second quarter outlook
  • Comparable sales decreased 1.4% year over year
  • Gross profit margin expanded approximately 120 basis points to 39.3% as a percentage of net sales
  • Operating income improved $40.6 million to $43.0 million
  • GAAP net income improved $38.8 million to $14.0 million
  • Adjusted EBITDA1 increased $30.3 million to $113.9 million

"For the second quarter we once again delivered against our commitments, enabling us to raise our earnings outlook for the full year. The first half of this year established a solid foundation for our transformation as we continued to strengthen our economic model and improve retail operating fundamentals," said Joel Anderson,Petco's Chief Executive Officer.

"As we look ahead to the remainder of this year, we will continue to execute on our objectives while also leaning into select targeted investments that we believe will help set the stage for a return to sustainable profitable growth."

Full Year 2025 Outlook

The company maintained its full year net sales outlook and raised its full year 2025 earnings outlook. In addition, the company provided its outlook for the third quarter of 2025. The Company's third quarter and full year 2025 outlook assumes that the tariffs on imports into the U.S. from China and other countries as of August 28, 2025 will stay at current or planned levels and do not increase for the remainder of the year.


FY 2025ܳٱǴǰ*

Net Sales

Down low single digits year over year

ܲٱնٴ

$385 million to $395 million

Net interest expense

~$130 million

CapitalExpenditures

$125 million to $130 million

Depreciation & Amortization

~$200 million

Net Store Closures

~25

Third Quarter 2025 Outlook


Q3 2025 Outlook*

Net Sales

Down low single digits year over year

ܲٱնٴ

$92 million to $94 million

*Assumptions in the outlook include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent, and that current or planned tariffs on imports into the U.S. from other countries remain at August 28, 2025 levels. Adjusted EBITDA is a non-GAAP financial measure and has not been reconciled to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlook for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA are made in a manner consistent with the relevant definitions and assumptions noted herein and in our filings with the Securities and Exchange Commission.

(1)

Adjusted EBITDA is a non-GAAP financial measure. See "Non-GAAP Financial Measures" for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures.

Earnings Conference Call Webcast Information:

Management will host an earnings conference call on August 28, 2025 at approximately 4:30 PM Eastern Time to discuss the company's financial results. A live webcast of the conference call will be available on the company's Investor Relations page at.A replay of the webcast will be available through the same link approximately two hours after the conference call.

About Petco:

We're proud to be "where the pets go" to find everything they need to live their best lives for more than 60 years � from their favorite meals and toys, to trusted supplies and expert support from people who get it, because we live it. We believe in the universal truths of pet parenthood � the boundlessboops, missing slippers, late night zoomies and everything in between. And we're here for it. Every tail wag, every vet visit, every step of the way. We nurture the pet-human bond in the aisles of more than 1,500 Petco stores across the U.S., Mexico and Puerto Rico. Customers experience our exclusive selection of pet care products, services, expertise and membership offerings in stores and online at petco.com, and on the Petco app. In 1999, we founded Petco Love. Together, we support thousands of local animal welfare groups nationwide, and have helped find homes for ~7 million animals through in-store adoption events.

Forward-Looking Statements:

This earnings release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact, including, but not limited to, statements regarding our Q3 and full year 2025 outlook, operational reset of our business, our competitive positioning, profitability, cost action plans and associated cost-savings, and our expectations regarding tariffs and associated impacts. Such forward-looking statements can generally be identified by the use of forward-looking terms such as "believes," "expects," "may," "intends," "will," "shall," "should," "anticipates," "opportunity," "illustrative," or the negative thereof or other variations thereon or comparable terminology. Although Petco believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these expectations will prove to be correct or that any forward-looking results will occur or be realized. Nothing contained in this earnings release is, or should be relied upon as, a promise or representation or warranty as to any future matter, including any matter in respect of the operations or business or financial condition of Petco. All forward-looking statements are based on current expectations and assumptions about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and contingencies, many of which are outside the control of Petco. Forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results or events to differ materially from the potential results or events discussed in the forward-looking statements, including, without limitation, those identified in this earnings release as well as the following: (i) increased competition (including from multi-channel retailers, mass and grocery retailers, and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments; (vi) macroeconomic pressures in the markets in which we operate, including inflation, prevailing interest rates and the impact of tariffs; (vii) failure to effectively manage our costs; (viii) our reliance on our information technology systems; (ix) our ability to prevent or effectively respond to a data privacy or security breach; (x) our ability to effectively manage or integrate strategic ventures, alliances or acquisitions and realize the anticipated benefits of such transactions; (xi) economic or regulatory developments that might affect our ability to provide attractive promotional financing; (xii) business interruptions and other supply chain issues; (xiii) catastrophic events, political tensions, conflicts and wars (such as the ongoing conflicts in Ukraine and the Middle East), health crises, and pandemics; (xiv) our ability to maintain positive brand perception and recognition; (xv) product safety and quality concerns; (xvi) changes to labor or employment laws or regulations; (xvii) our ability to effectively manage our real estate portfolio; (xviii) constraints in the capital markets or our vendor credit terms; (xix) changes in our credit ratings; (xx) impairments of the carrying value of our goodwill and other intangible assets; (xxi) our ability to successfully implement our operational adjustments, achieve the expected benefits of our cost action plans and drive improved profitability; and (xxii) the other risks, uncertainties and other factors identified under "Risk Factors" and elsewhere in Petco's Securities and Exchange Commission filings. The occurrence of any such factors could significantly alter the results set forth in these statements.

Petco cautions that the foregoing list of risks, uncertainties and other factors is not complete, and forward-looking statements speak only as of the date they are made. Petco undertakes no duty to update publicly any such forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent legal authority.

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited and subject to reclassification)












13 Weeks Ended


26 Weeks Ended



August 2,
2025


August 3,
2024


August 2,
2025


August 3,
2024

Net sales:









Products


$ 1,225,605


$ 1,263,749


$ 2,467,496


$ 2,543,480

Services and other


262,924


260,006


514,432


509,415

Total net sales


1,488,529


1,523,755


2,981,928


3,052,895

Cost of sales:









Products


747,143


787,103


1,513,428


1,579,825

Services and other


156,067


155,927


313,213


313,685

Total cost of sales


903,210


943,030


1,826,641


1,893,510

Gross profit


585,319


580,725


1,155,287


1,159,385

Selling, general and administrative expenses


542,297


578,257


1,095,906


1,173,699

Operating income (loss)


43,022


2,468


59,381


(14,314)

Interest income


(909)


(672)


(2,268)


(1,090)

Interest expense


33,297


36,805


66,791


73,622

Other non-operating loss





2,665

Income (loss) before income taxes and income from
equity method investees


10,634


(33,665)


(5,142)


(89,511)

Income tax expense (benefit)


746


(4,651)


1,241


(9,128)

Income from equity method investees


(4,084)


(4,191)


(8,694)


(9,077)

Net income (loss) attributable to Class A and B-1 common
stockholders


$ 13,972


$ (24,823)


$ 2,311


$ (71,306)










Net income (loss) per Class A and B-1 common share:









Basic


$ 0.05


$ (0.09)


$ 0.01


$ (0.26)

Diluted


$ 0.05


$ (0.09)


$ 0.01


$ (0.26)










Weighted average shares used in computing net income (loss) per Class A
and B-1 common share:









Basic


279,058


273,074


278,303


271,421

Diluted


285,741


273,074


284,350


271,421

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)

(Unaudited and subject to reclassification)






August 2,
2025


February 1,
2025

ASSETS





Current assets:





Cash and cash equivalents


$ 188,748


$ 165,756

Receivables, less allowance for credit losses1


34,524


40,425

Merchandise inventories, net


608,506


653,329

Prepaid expenses


60,387


53,515

Other current assets


47,393


60,594

Total current assets


939,558


973,619

Fixed assets


2,311,922


2,265,915

Less accumulated depreciation


(1,624,417)


(1,540,477)

Fixed assets, net


687,505


725,438

Operating lease right-of-use assets


1,314,618


1,302,346

Goodwill


980,064


980,064

Trade name


1,025,000


1,025,000

Other long-term assets


206,537


187,963

Total assets


$ 5,153,282


$ 5,194,430

LIABILITIES AND EQUITY





Current liabilities:





Accounts payable and book overdrafts


$ 423,269


$ 492,878

Accrued salaries and employee benefits


130,688


157,460

Accrued expenses and other liabilities


192,249


177,079

Current portion of operating lease liabilities


306,902


306,400

Current portion of long-term debt and other lease liabilities


5,458


5,346

Total current liabilities


1,058,566


1,139,163

Senior secured credit facilities, net, excluding current portion


1,580,688


1,578,091

Operating lease liabilities, excluding current portion


1,047,757


1,037,206

Deferred taxes, net


220,992


217,712

Other long-term liabilities


106,176


108,628

Total liabilities


4,014,179


4,080,800

Commitments and contingencies





Stockholders' equity:





Class A common stock2


242


239

Class B-1 common stock3


38


38

Class B-2 common stock4



Preferred stock5



Additional paid-in-capital


2,297,702


2,280,495

Accumulated deficit


(1,146,748)


(1,149,059)

Accumulated other comprehensive loss


(12,131)


(18,083)

Total stockholders' equity


1,139,103


1,113,630

Total liabilities and stockholders' equity


$ 5,153,282


$ 5,194,430






¹ Allowances for credit losses are $725 and $1,594, respectively

² Class A common stock, $0.001 par value: Authorized - 1.0 billion shares;
Issued and outstanding - 242.1 million and 239.1 million shares, respectively

³ Class B-1 common stock, $0.001 par value: Authorized - 75.0 million shares;
Issued and outstanding - 37.8 million shares

� Class B-2 common stock, $0.000001 par value: Authorized - 75.0 million shares;
Issued and outstanding - 37.8 million shares

� Preferred stock, $0.001 par value: Authorized - 25.0 million shares;
Issued and outstanding - none

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited and subject to reclassification)








26 Weeks Ended



August 2,
2025


August 3,
2024

Cash flows from operating activities:





Net income (loss)


$ 2,311


$ (71,306)

Adjustments to reconcile net income (loss) to net cash provided by
operating activities:





Depreciation and amortization


98,649


99,305

Amortization of debt discounts and issuance costs


2,499


2,435

Provision for deferred taxes


1,113


(27,782)

Equity-based compensation


18,209


29,348

Impairments, write-offs and losses on sale of fixed and other assets


522


7,069

Income from equity method investees


(8,694)


(9,077)

Amounts reclassified out of accumulated other comprehensive loss


(413)


(2,274)

Non-cash operating lease costs


205,005


207,605

Other non-operating loss



2,665

Changes in assets and liabilities:





Receivables


5,783


(2,083)

Merchandise inventories


44,823


11,769

Prepaid expenses and other assets


(9,487)


(7,166)

Accounts payable and book overdrafts


(69,691)


(9,644)

Accrued salaries and employee benefits


(26,729)


34,591

Accrued expenses and other liabilities


14,508


3,015

Operating lease liabilities


(206,414)


(209,738)

Other long-term liabilities


(1,556)


2,224

Net cash provided by operating activities


70,438


60,956

Cash flows from investing activities:





Cash paid for fixed assets


(60,516)


(60,029)

Cash paid for acquisitions, net of cash acquired



(259)

Proceeds from investment



998

Proceeds from sale of assets


2,425


1,019

Cash received from partial surrender of officers' life insurance



206

Net cash used in investing activities


(58,091)


(58,065)

Cash flows from financing activities:





Borrowings under long-term debt agreements



201,000

Repayments of long-term debt



(201,000)

Debt refinancing costs



(3,028)

Payments for finance lease liabilities


(3,252)


(3,528)

Proceeds from employee stock purchase plan and stock option exercises


1,998


1,630

Tax withholdings on stock-based awards


(3,026)


(3,468)

Proceeds from issuance of common stock



2,500

Net cash used in financing activities


(4,280)


(5,894)






Net decrease in cash, cash equivalents and restricted cash


8,067


(3,003)

Cash, cash equivalents and restricted cash at beginning of period


181,665


136,649

Cash, cash equivalents and restricted cash at end of period


$ 189,732


$ 133,646

NON-GAAP FINANCIAL MEASURES

The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this earnings release to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP). The company has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in this earnings release that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in this earnings release. The non-GAAP financial measures in this earnings release may differ from similarly titled measures used by other companies.

Adjusted EBITDA

Adjusted EBITDA is considered a non-GAAP financial measure under the Securities and Exchange Commission's (SEC) rules because it excludes certain amounts included in net income calculated in accordance with GAAP. Management believes that Adjusted EBITDA is a meaningful measure to share with investors because it facilitates comparison of the current period performance with that of the comparable prior period. In addition, Adjusted EBITDA affords investors a view of what management considers to be Petco's core operating performance as well as the ability to make a more informed assessment of such operating performance as compared with that of the prior period. Please see the company's Annual Report on Form 10-K for the fiscal year ended February 1, 2025 filed with the SEC on March 31, 2025 for additional information on Adjusted EBITDA.

The table below reflects the calculation of Adjusted EBITDA for the thirteen and twenty-six weeks ended August 2, 2025 compared to the thirteen and twenty-six weeks ended August 3, 2024.

(dollars in thousands)


13 Weeks Ended


26 Weeks Ended

Reconciliation of Net Income (Loss) Attributable to Class A and B-1
Common Stockholders to Adjusted EBITDA


August 2,
2025


August 3,
2024


August 2,
2025


August 3,
2024

Net income (loss) attributable to Class A and B-1 common stockholders


$ 13,972


$ (24,823)


$ 2,311


$ (71,306)

Add (deduct):









Interest expense, net


32,388


36,133


64,523


72,532

Income tax expense (benefit)


746


(4,651)


1,241


(9,128)

Depreciation and amortization


49,284


49,718


98,649


99,305

Income from equity method investees


(4,084)


(4,191)


(8,694)


(9,077)

Asset impairments and write offs


76


3,561


522


7,069

Equity-based compensation


8,789


11,914


18,209


29,348

Other non-operating loss





2,665

Mexico joint venture EBITDA (1)


10,360


9,902


20,558


20,398

Acquisition and divestiture-related costs (2)





3,719

Other costs (3)


2,329


5,960


5,990


13,642

Adjusted EBITDA


$ 113,860


$ 83,523


$ 203,309


$ 159,167

Net sales


$ 1,488,529


$ 1,523,755


$ 2,981,928


$ 3,052,895

Net margin (4)


0.9%


(1.6%)


0.1%


(2.3%)

Adjusted EBITDA Margin


7.6%


5.5%


6.8%


5.2%

(1)

Mexico joint venture EBITDA represents 50 percent of the entity's operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA. In the financial statements, this joint venture is accounted for as an equity method investment and reported net of depreciation and income taxes because such a presentation would not reflect the adjustments made in the calculation of Adjusted EBITDA, we include the 50 percent interest in the company's Mexico joint venture on an Adjusted EBITDA basis to ensure consistency. The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA.



13 Weeks Ended


26 Weeks Ended

(in thousands)


August 2,
2025


August 3,
2024


August 2,
2025


August 3,
2024

Net income


$ 8,167


$ 8,822


$ 17,387


$ 18,377

Depreciation


6,793


6,996


13,390


13,944

Income tax expense


3,935


3,903


8,101


7,359

Foreign currency loss (gain)


696


(380)


404


99

Interest expense, net


1,129


463


1,833


1,016

EBITDA


$ 20,720


$ 19,804


$ 41,115


$ 40,795

50% of EBITDA


$ 10,360


$ 9,902


$ 20,558


$ 20,398

(2)

Acquisition and divestiture-related integration costs include direct costs resulting from acquiring, integrating, or divesting businesses. These include third-party professional and legal fees, losses on sales of divestitures, and other integration-related costs that would not have otherwise been incurred as part of the company's operations.



(3)

Other costs include, as incurred: restructuring costs and restructuring-related severance costs; legal reserves associated with significant, non-ordinary course legal or regulatory matters; and costs related to certain significant strategic transactions.



(4)

We define net margin as net loss attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales.

Free Cash Flow

Free Cash Flow is a non-GAAP financial measure that is calculated as net cash provided by operating activities less cash paid for fixed assets. Management believes that Free Cash Flow, which measures the ability to generate additional cash from business operations, is an important financial measure for use in evaluating the company's financial performance.

The table below reflects the calculation of Free Cash Flow for the thirteen and twenty-six weeks endedAugust 2, 2025 compared to the thirteen and twenty-six weeks ended August 3, 2024.

(in thousands)


13 Weeks Ended


26 Weeks Ended



August 2,
2025


August 3,
2024


August 2,
2025


August 3,
2024

Net cash provided by operating activities


$ 85,892


$ 69,370


$ 70,438


$ 60,956

Cash paid for fixed assets


(32,104)


(27,388)


(60,516)


(60,029)

Free Cash Flow


$ 53,788


$ 41,982


$ 9,922


$ 927

Cision View original content to download multimedia:

SOURCE Petco - Investor Relations

FAQ

What were Petco's (WOOF) Q2 2025 earnings results?

Petco reported net sales of $1.5 billion (down 2.3% YoY), with improved profitability including operating income of $43.0 million and net income of $14.0 million. Gross margin expanded to 39.3%.

What is Petco's (WOOF) guidance for full year 2025?

Petco expects net sales to decline in low single digits year over year, with Adjusted EBITDA between $385-395 million. Capital expenditures are projected at $125-130 million.

How many stores does Petco plan to close in 2025?

Petco plans approximately 25 net store closures during fiscal year 2025.

What is Petco's Q3 2025 outlook?

For Q3 2025, Petco expects net sales to decline in low single digits year over year and projects Adjusted EBITDA between $92-94 million.

How did Petco's comparable sales perform in Q2 2025?

Petco's comparable sales decreased 1.4% year over year in Q2 2025.
Petco Health & Wellness Company, Inc.

NASDAQ:WOOF

WOOF Rankings

WOOF Latest News

WOOF Latest SEC Filings

WOOF Stock Data

887.18M
83.89M
4.72%
127.14%
6.77%
Specialty Retail
Retail-retail Stores, Nec
United States
SAN DIEGO